Update on Small-Cell Lung Cancer

Update on Small-Cell Lung Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: SCLC Overview: Presentation, Staging, and Complications

February 28th 2020

EP. 2: Optimal Management of Limited-Stage SCLC

February 28th 2020

EP. 3: Addressing the Aggressive Nature of SCLC

February 28th 2020

EP. 4: Chemoimmunotherapy for ES SCLC: IMpower133 Trial

February 28th 2020

EP. 5: Chemoimmunotherapy for ES SCLC: CASPIAN Trial

February 28th 2020

EP. 6: Treatment of Relapsed/Refractory SCLC

February 28th 2020

EP. 7: Lurbinectedins Role in Managing SCLC

February 28th 2020

EP. 8: Emerging Treatment Options for SCLC

February 28th 2020

EP. 9: Small-Cell Lung Cancer: Future Directions in Care

February 28th 2020

Trending on OncLive

Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC

SERENA-4 Misses Primary PFS End Point With Camizestrant Plus Palbociclib in First-Line ER+ Advanced Breast Cancer

Dibotatug Is Safe and Yields Durable Responses in Large Granular Lymphocytic Leukemia

Asciminib Maintains Superior MMR and Favorable Safety at 3 Years in Newly Diagnosed Ph+ CML

FDA Extends Review Period for Zanzalintinib Plus Atezolizumab NDA in Pretreated mCRC